Eastman Chemical (EMN) shares were down more than 20% in recent Friday trading after UBS and Mizuho cut their price targets on the stock, following the company's Q2 results that missed market expectations..
UBS lowered its price target to $86 from $101 while maintaining a buy rating.
"We see no way around having a negative view on the quarter and outlook for 2H. [Q2] missed a lower bar (7% below consensus), and [Q3] guided at $1.25 is 35% below consensus," UBS Securities said in a note.
Additionally, Mizuho Securities trimmed its target to $80 from $92 and kept an outperform rating.
Eastman reported adjusted Q2 earnings of $1.60 per share, down from $2.15 a year earlier and below the $1.73 consensus. Revenue slipped to $2.29 billion from $2.36 billion, missing estimates for $2.3 billion.
Price: 57.80, Change: -14.81, Percent Change: -20.40
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.